Bill > SB00152

This bill introduces the Human Cell Product Labeling Act, which requires businesses operating in the state to provide clear warnings about products developed or tested using human cells. Specifically, businesses must disclose to consumers that a product was developed or tested with human cells and provide an internet web address that details three key pieces of information: the origin of the human cells, the method by which those cells were obtained, and the medical or scientific name of the human cell base line used in product development or testing. If a business fails to provide this mandatory warning, they may face civil or criminal penalties. The legislation aims to increase transparency for consumers by ensuring they have access to information about the human cellular components used in product development, allowing individuals to make more informed purchasing decisions about products that involve human cell research or testing.

Justice

https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=SB00152&which_year=2025